To investigate whether Bcl-xL up-regulation inhibits the antitumor activity of rapamycinin CCA, we treated nude mice suffering QBC939 xenografts with Bcl-xL inhibitor ABT-737 or/and rapamycin. Here, BCL2L1 is linked to cholangiocarcinoma.